Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $247,388 | 155 | 97.2% |
| Food and Beverage | $5,844 | 479 | 2.3% |
| Travel and Lodging | $1,158 | 11 | 0.5% |
| Education | $19.90 | 2 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | $173,598 | 130 | $0 (2024) |
| Shire North American Group Inc | $75,056 | 44 | $0 (2019) |
| Novo Nordisk Inc | $920.70 | 135 | $0 (2023) |
| ABBVIE INC. | $833.75 | 65 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $523.60 | 31 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $430.02 | 31 | $0 (2024) |
| Lilly USA, LLC | $344.86 | 25 | $0 (2024) |
| PFIZER INC. | $327.29 | 28 | $0 (2024) |
| Amgen Inc. | $308.26 | 21 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $235.89 | 18 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $34,023 | 69 | Takeda Pharmaceuticals U.S.A., Inc. ($33,267) |
| 2023 | $30,089 | 81 | Takeda Pharmaceuticals U.S.A., Inc. ($29,217) |
| 2022 | $42,453 | 94 | Takeda Pharmaceuticals U.S.A., Inc. ($41,622) |
| 2021 | $45,158 | 92 | Takeda Pharmaceuticals U.S.A., Inc. ($44,445) |
| 2020 | $25,601 | 68 | Takeda Pharmaceuticals U.S.A., Inc. ($25,009) |
| 2019 | $32,215 | 81 | Shire North American Group Inc ($31,656) |
| 2018 | $21,601 | 78 | Shire North American Group Inc ($20,900) |
| 2017 | $23,270 | 84 | Shire North American Group Inc ($22,500) |
All Payment Transactions
647 individual payment records from CMS Open Payments — Page 1 of 26
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/27/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $28.49 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 12/23/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.66 | General |
| Category: Gastroenterology | ||||||
| 12/16/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $1,100.00 | General |
| 12/04/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $13.15 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/21/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.41 | General |
| Category: RESPIRATORY | ||||||
| 11/19/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $15.45 | General |
| Category: UROLOGY | ||||||
| 11/13/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,200.00 | General |
| 11/12/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $15.89 | General |
| Category: Diabetes | ||||||
| 11/05/2024 | Radius Health, Inc. | Tymlos (Drug) | Food and Beverage | In-kind items and services | $15.30 | General |
| Category: Endocrinology | ||||||
| 11/01/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.92 | General |
| Category: NEUROSCIENCE | ||||||
| 10/29/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.05 | General |
| Category: Respiratory | ||||||
| 10/25/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.20 | General |
| Category: RESPIRATORY | ||||||
| 10/22/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $17.42 | General |
| Category: Bone Health | ||||||
| 10/09/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,200.00 | General |
| 10/02/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $550.00 | General |
| 09/27/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $18.71 | General |
| Category: VACCINES | ||||||
| 09/24/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.05 | General |
| Category: Respiratory | ||||||
| 09/20/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $21.35 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/17/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $13.94 | General |
| Category: DIABETES | ||||||
| 09/13/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $1,100.00 | General |
| 09/11/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,200.00 | General |
| 09/10/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $14.67 | General |
| Category: Diabetes | ||||||
| 08/27/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.57 | General |
| Category: Respiratory | ||||||
| 08/23/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $16.38 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 08/13/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $23.59 | General |
| Category: Cardiovascular and Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 1,474 | 2,702 | $217,347 | $100,728 |
| 2022 | 21 | 1,532 | 2,477 | $205,271 | $86,328 |
| 2021 | 22 | 1,536 | 2,751 | $217,532 | $128,779 |
| 2020 | 22 | 1,601 | 2,544 | $208,044 | $124,502 |
All Medicare Procedures & Services
82 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 200 | 954 | $62,010 | $36,595 | 59.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 249 | 492 | $46,740 | $13,741 | 29.4% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 192 | 204 | $24,480 | $13,085 | 53.5% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 44 | 44 | $11,855 | $11,618 | 98.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 190 | 190 | $28,500 | $8,197 | 28.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 117 | 157 | $20,410 | $6,276 | 30.7% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 24 | 24 | $4,200 | $1,992 | 47.4% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 26 | 30 | $5,250 | $1,845 | 35.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 64 | 64 | $1,600 | $1,568 | 98.0% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 81 | 152 | $4,560 | $1,428 | 31.3% |
| 90688 | Influenza vaccine, quadrivalent, 0.5 ml dosage | Office | 2023 | 64 | 64 | $1,920 | $1,309 | 68.2% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 44 | 44 | $1,100 | $1,078 | 98.0% |
| 69210 | Removal of impacted ear wax | Office | 2023 | 27 | 35 | $2,100 | $1,012 | 48.2% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2023 | 83 | 164 | $1,312 | $520.02 | 39.6% |
| 81000 | Manual urinalysis test with examination using microscope, non-automated | Office | 2023 | 30 | 45 | $360.00 | $177.30 | 49.3% |
| 82044 | Urine microalbumin (protein) analysis | Office | 2023 | 25 | 25 | $250.00 | $152.75 | 61.1% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 14 | 14 | $700.00 | $132.90 | 19.0% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 198 | 769 | $49,985 | $22,973 | 46.0% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 179 | 189 | $22,680 | $14,771 | 65.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 245 | 427 | $40,565 | $11,909 | 29.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 170 | 214 | $27,820 | $8,756 | 31.5% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 30 | 30 | $7,550 | $7,189 | 95.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 161 | 161 | $24,175 | $6,788 | 28.1% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2022 | 47 | 47 | $8,225 | $2,573 | 31.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 76 | 76 | $1,895 | $1,833 | 96.7% |
About Dr. David Neidhardt, MD
Dr. David Neidhardt, MD is a Family Medicine healthcare provider based in Lima, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/16/2006. The National Provider Identifier (NPI) number assigned to this provider is 1396797510.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Neidhardt, MD has received a total of $254,409 in payments from pharmaceutical and medical device companies, with $34,023 received in 2024. These payments were reported across 647 transactions from 39 companies. The most common payment nature is "Consulting Fee" ($247,388).
As a Medicare-enrolled provider, Neidhardt has provided services to 6,143 Medicare beneficiaries, totaling 10,474 services with total Medicare billing of $440,337. Data is available for 4 years (2020–2023), covering 82 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Lima, OH
- Active Since 05/16/2006
- Last Updated 06/04/2008
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1396797510
Products in Payments
- Ozempic (Drug) $533.70
- JARDIANCE (Drug) $369.36
- FARXIGA (Drug) $337.79
- VRAYLAR (Drug) $244.21
- LINZESS (Drug) $235.65
- UBRELVY (Drug) $206.60
- XIFAXAN (Drug) $201.37
- XARELTO (Drug) $192.13
- ENTRESTO (Drug) $190.08
- Victoza (Drug) $165.24
- EVENITY (Biological) $147.01
- SOLIQUA 100/33 (Biological) $138.77
- STIOLTO RESPIMAT (Drug) $121.11
- Livalo (Drug) $117.39
- MOUNJARO (Drug) $116.93
- QULIPTA (Drug) $109.11
- TRULICITY (Drug) $97.39
- JANUVIA (Drug) $91.99
- VIBERZI (Drug) $90.33
- GEMTESA (Drug) $85.24
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Lima
Dr. William Leahy, Md, MD
Family Medicine — Payments: $21,475
Dr. Manu Aggarwal, Md, MD
Family Medicine — Payments: $14,371
Mark Mueller, M.d, M.D
Family Medicine — Payments: $7,886
Edward Tremoulis, Md, MD
Family Medicine — Payments: $6,600
Dr. Salim Hanna, M.d, M.D
Family Medicine — Payments: $5,805
Madeline Agosto, M.d, M.D
Family Medicine — Payments: $3,225